An Open, Single Centre, Single and Repeated Dose Study to Investigate the Pharmacokinetic Profile of Roflumilast and Roflumilast N-oxide After Administration of 500 μg Dose of Roflumilast in Healthy Chinese Subjects.
Phase of Trial: Phase I
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Roflumilast (Primary)
- Indications Asthma
- Focus Pharmacokinetics
- 04 May 2012 Company added as trial association as reported by ClinicalTrials.gov.
- 21 Nov 2011 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 08 Aug 2011 Status changed from recruiting to completed.